Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 23, 2024

A Remote Management Program Improves the Utilization of GDMT in Patients With Type 2 Diabetes at High Cardiovascular and/or Kidney Risk



Additional Info

Disclosure statements are available on the authors' profiles:

Randomized Evaluation of a Remote Management Program to Improve Guideline-directed Medical Therapy: The Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) Trial
Circulation 2024 Apr 07;[EPub Ahead of Print], AJ Blood, LS Chang, S Hassan, J Chasse, G Stern, D Gabovitch, D Zelle, C Colling, SJ Aronson, C Figueroa, E Collins, R Ruggiero, E Zacherle, J Noone, C Robar, J Plutzky, TA Gaziano, CP Cannon, DJ Wexler, BM Scirica

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading